2009
DOI: 10.1080/00365510902811253
|View full text |Cite
|
Sign up to set email alerts
|

Are eGFR equations better than IDMS-traceable serum creatinine in classifying chronic kidney disease?

Abstract: We show that neither the MDRD study equation nor the Mayo Clinic equation add extra value to the information already contained in Scr itself. Because of the limited applicability of the eGFR equations, Scr has even more potential to assist in the diagnosis and classification of CKD than eGFR-MDRD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…It could be considered controversial in 2017 to assert that the estimating GFR (eGFR) by creatinine-based equations does not contain more information than the biomarker concentration itself, even if some authors have already claimed this [22,23] . It is true that the use of eGFR allows one better to take into account the variation of serum creatinine due to ethnicity, gender and age, these being the variables in the current eGFR equations [24][25][26][27][28] .…”
Section: Estimating Gfr Equations: a Solution That Generates Other Ismentioning
confidence: 99%
“…It could be considered controversial in 2017 to assert that the estimating GFR (eGFR) by creatinine-based equations does not contain more information than the biomarker concentration itself, even if some authors have already claimed this [22,23] . It is true that the use of eGFR allows one better to take into account the variation of serum creatinine due to ethnicity, gender and age, these being the variables in the current eGFR equations [24][25][26][27][28] .…”
Section: Estimating Gfr Equations: a Solution That Generates Other Ismentioning
confidence: 99%
“…Conversely, when considering the eGFR results in population studies, such a systematic error will be misleading in terms of CKD prevalence or CKD-related mortality and morbidity-associated risk [15,16]. This was specifically observed with the MDRD equation, which by underestimating the mean mGFR, overestimates the CKD stage 3 prevalence in the general population [7,[15][16][17][18].…”
Section: A S S E S S I N G T H E P E R Fo R M a N C E O F E Q U At I mentioning
confidence: 99%
“…While the reference range for eGFR should be narrower than that for serum creatinine, the eGFR essentially has no reference range because only quantitative results ≤60 ml/min/1.73 m 2 are reported, which prevents its use for detecting early changes in renal function or for evaluating persons with normal renal function. Pottel and Martens [15] present a provocative report claiming that the MDRD eGFR adds little to a simple creatinine compared to appropriate reference intervals based on age for males and females. Furthermore, they show that the stages of kidney disease can be classified by the serum creatinine values as well as by the GFR.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, they show that the stages of kidney disease can be classified by the serum creatinine values as well as by the GFR. Using their data for males and females aged 50–54 years [table 1a, [15]], the stages of CKD can be associated with appropriate ranges for serum creatinine (table 1). …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation